Relx Plc (NYSE:RELX) Shares Sold by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC decreased its holdings in shares of Relx Plc (NYSE:RELX - Free Report) by 10.3% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 41,709 shares of the technology company's stock after selling 4,767 shares during the period. Wealth Enhancement Advisory Services LLC's holdings in Relx were worth $2,103,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in RELX. Transce3nd LLC acquired a new stake in Relx in the fourth quarter valued at about $40,000. Brown Brothers Harriman & Co. lifted its position in Relx by 218.5% in the fourth quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock valued at $44,000 after purchasing an additional 662 shares during the period. Private Trust Co. NA lifted its position in Relx by 19.2% in the fourth quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock valued at $56,000 after purchasing an additional 199 shares during the period. Whipplewood Advisors LLC acquired a new stake in Relx in the fourth quarter valued at about $74,000. Finally, Redwood Investments LLC acquired a new stake in Relx in the fourth quarter valued at about $120,000. Institutional investors and hedge funds own 15.02% of the company's stock.

Relx Trading Up 0.9%

Shares of Relx stock opened at $53.78 on Friday. Relx Plc has a 12-month low of $43.45 and a 12-month high of $56.33. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46. The stock has a market cap of $100.98 billion, a PE ratio of 28.91, a price-to-earnings-growth ratio of 3.24 and a beta of 0.84. The company has a 50-day moving average of $53.76 and a two-hundred day moving average of $50.36.

Analyst Ratings Changes

A number of equities research analysts recently commented on the stock. Barclays upgraded shares of Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. Morgan Stanley reaffirmed an "overweight" rating on shares of Relx in a report on Wednesday, April 16th. Wall Street Zen cut shares of Relx from a "buy" rating to a "hold" rating in a report on Tuesday, March 4th. Finally, The Goldman Sachs Group started coverage on shares of Relx in a report on Wednesday, March 26th. They issued a "buy" rating for the company. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Buy".

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.